HENDERSON MOLLY (CFO and CBO) sold 6.0% of their position (6.31K shares) of PHATHOM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $48.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/22/2024ACC: 0001209191-24-002021
Officer· CFO and CBO
Since Apr 2022
+113.69K
Net shares
Net buyer
$48.9K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
120K acquired · 6.31K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−6.31K
Price / share
$7.75
Trade value
$48.90K
% of position
6.0%
1/19/2024
105K→98.70K
Total
Net shares
−6.31K
Net value
-$48.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/19/2024 | S · Sale | −6.31K | $7.75 | $48.90K | 6.0% | 105K | 98.70K |
| Total | −6.31K | -$48.90K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
120K shares
Shares
+120K
Strike price
7.60
Held after
120K
Exercisable
—
1/18/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock120K shares | 1/18/2024 | A · Award | +120K | 7.60 | — | 120K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.91K
Total
1.91K indirect1.91K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.91K | Indirect |
| Total | 1.91K | 1.91K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported